Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell therapy: achievements and perspectives.

C Bordignon1, C Carlo-Stella, M P Colombo

  • 1Institute of Hematology, S. Raffaele Hospital, Milan, Italy.

Haematologica
|December 10, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Iodine Nutrition in Emilia-Romagna Region, Italy: A Successful Story of Prevention of Iodine Deficiency Disorders.

Endocrine, metabolic & immune disorders drug targets·2026
Same author

Transfusion dependence is a risk factor for severe infections in myelodysplastic syndromes.

Leukemia research·2022
Same author

Inner southern magnetosphere observation of Mercury via SERENA ion sensors in BepiColombo mission.

Nature communications·2022
Same author

Stochastic epigenetic mutations as possible explanation for phenotypical discordance among twins with congenital hypothyroidism.

Journal of endocrinological investigation·2022
Same author

Phototherapy and topical treatments for cutaneous graft vs. host disease in haematopoietic stem cell transplantation patients: a scoping review.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Recurrence-specific supervised graph clustering for subtyping Hodgkin Lymphoma radiomic phenotypes.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2021

Cell therapy offers promising strategies for replacing or repairing damaged tissues. Current research examines its utilization in clinical hematology, focusing on advancements in hematopoietic cell applications.

Area of Science:

  • Hematopoietic cell therapy leverages autologous or allogeneic cells for tissue repair and functional enhancement.
  • Significant advancements in cell therapy have spurred a review of its current clinical applications in hematology.

Background:

  • Historically, Lymphokine-Activated Killer (LAK) and Tumor-Infiltrating Lymphocytes (TIL) have shown limited documented benefits in solid tumors.
  • Adoptive immunotherapy with donor lymphocyte infusions is effective for hematologic remission in chronic myeloid leukemia relapse post-allograft.
  • Donor T-cell infusions can treat Epstein-Barr virus-induced post-transplant lymphoproliferative disorders.

Framework:

  • Dendritic cell-based immunotherapy shows promise for anti-tumor activity, with strategies to induce antileukemic responses.
  • Marrow Mesenchymal Stem Cells (MSCs) possess hematopoietic regulatory roles, with prerequisites for clinical applications being discussed.

Related Experiment Videos

Implementation:

  • The review employed informal consensus development among Working Group members, analyzing previously identified problems.
  • Literature search included peer-reviewed journals indexed in Science Citation Index and Medline.

Implications:

  • Further exploration of LAK or activated Natural Killer (NK) cells in hematologic patients with low tumor burden is warranted.
  • Enhancing NK cell antineoplastic activity and using selected NK cells for graft-versus-leukemia (GVL) while avoiding graft-versus-host disease (GvHD) are promising.
  • Strategies to improve immune reconstitution and restore anti-infectious functions post-hematopoietic stem cell transplantation are crucial.